COVID-19 (+) n=46 COVID-19 (-) n=45
p value
Age (years) 46.5 (36.8-55.0) 37.0 (32.0-55.0) 0.194
Male, n (%) 32 (69.6) 27 (60.0) 0.231
Etiology of CKD Etiology of CKD Etiology of CKD Etiology of CKD
Diabetes Mellitus, n (%) 5 (10.9) 3 (6.7) 0.599
Glomerulonephritis, n (%) 8 (17.4) 11 (24.4)
Others, n (%) 33 (71.7) 31 (68.9)
Living donor, n (%) 36 (78.3) 35 (77.8) 0.600
Transplantation Duration (months) 108.0 (48.0-147.0) 84.0 (24.0-132.0) 0.378
COVID-19 in a household member, n (%) 29 (64.4) 3 (6.8) <0.001
Comorbidities Comorbidities Comorbidities Comorbidities
Diabetes, n (%) 13 (28.3) 11 (24.4) 0.431
Hypertension, n (%) 31 (67.4) 26 (57.8) 0.232
BMI (kg/m2) 27.4 ± 4.5 24.7 ± 4.2 0.004
Serum Creatinine (mg/dL) 1.28 (1.01-1.53) 1.23 (1.02-1.72) 0.778
e-GFR† (ml/min/1.73 m2) 64.9 ± 24.1 64.6 ± 31.6 0.955
Baseline immunosuppression Baseline immunosuppression Baseline immunosuppression Baseline immunosuppression
Steroids, n (%) 46 (100.0) 42 (93.3) 0.117
Calcineurin inhibitor, n (%) 43 (93.5) 43 (95.6) 0.511
Mycophenolic acid derivates, n (%) 41 (89.1) 35 (77.8) 0.119
m-TOR inhibitors, n (%) 4 (8.7) 4 (8.9) 0.631
Azathioprine, n (%) 3 (6.5) 7 (15.6) 0.149